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A B S T R A C T
Mammary glands are unique organs in which major adaptive changes occur in morphogenesis and development
after birth. Breast cancer is the most common cancer and a major cause of mortality in females worldwide. We
have previously identified the loss of expression of the transcription regulator DC-SCRIPT (Zfp366) as a prominent
prognostic event in estrogen receptor positive breast cancer patients. DC-SCRIPT affects multiple transcriptional
events in breast cancer cells, including estrogen and progesterone receptor-mediated transcription, and promotes
CDKN2B-related cell cycle arrest. As loss of DC-SCRIPT expression appears an early event in breast cancer
development, we here investigated the role of DC-SCRIPT in mammary gland development using wild-type and
DC-SCRIPT knockout mice. Mice lacking DC-SCRIPT exhibited severe breeding problems and showed significant
growth delay relative to littermate wild-type mice. Subsequent analysis revealed that DC-SCRIPT was expressed in
mouse mammary epithelium and that DC-SCRIPT deficiency delayed mammary gland morphogenesis in vivo.
Finally, analysis of 3D mammary gland organoid cultures confirmed that loss of DC-SCRIPT dramatically delayed
mammary organoid branching in vitro. The study shows for the first time that DC-SCRIPT deficiency delays
mammary gland morphogenesis in vivo and in vitro. These data define DC-SCRIPT as a novel modulator of
mammary gland development.
1. Introduction
The transcription factor dendritic cell specific transcript (DC-SCRIPT
or Zfp366) was originally identified in dendritic cells (DCs) and shown to
be also present in ductal epithelial cells (Triantis et al., 2006a, 2006b;
Ansems et al., 2010a). Subsequent studies in epithelial cancers identified
loss of DC-SCRIPT expression as a significant prognostic marker in es-
trogen receptor (ER) positive breast cancer patients (Ansems et al.,
2010a; Sieuwerts et al., 2010). In breast tumor cells, DC-SCRIPT acts as a
coregulator of multiple type I and type II nuclear receptors (NRs)
governing breast cancer cell fate decisions during breast cancer pro-
gression (Ansems et al., 2010a; Sieuwerts et al., 2010). Strikingly,
DC-SCRIPT displays repressive activity on type I NR-mediated tran-
scription (ER, Progesterone Receptor), while at the same time stimulating
the anti-proliferative type II NRs (Peroxisome Proliferator Activated
Receptor, Retinoic Acid Receptor) (Ansems et al., 2010a, 2010b, 2012).
In line with DC-SCRIPT acting as a breast cancer suppressor, we recently
reported that DC-SCRIPT induces cell cycle arrest through promoting
CDKN2B expression in ER positive breast cancer cells (Ansems et al.,
2015). The presence of DC-SCRIPT in MCF7 breast cancer cell line via a
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doxycycline-induced system not only reduces cell viability in vitro but
also inhibits tumor growth in an in vivo MCF7 cell line derived tumor
xenografts model (Ansems et al., 2015). In DCs, DC-SCRIPT was shown to
regulate IL-10 expression via modulating DUSP4 (Dual Specificity Phos-
phatase 4) activity, MAPK (Mitogen-activated protein kinases) signaling
and activation and binding of NF-κBp65 to the IL10 enhancer (Triantis
et al., 2006a; Sondergaard et al., 2015, 2018). In addition, DC-SCRIPT
also functions as a corepressor of glucocorticoid receptor-mediated
transcription in human monocyte–derived DCs (Hontelez et al., 2013).
These data show that DC-SCRIPT can affect both NR-mediated tran-
scriptional processes as well as the MAPK signaling pathway.
The NR-mediated regulatory networks driven by reproductive hor-
mones that are regulated by DC-SCRIPT are also known to be crucial for
mammary gland development (Brisken, 2002; Brisken and O'Malley,
2010). Mammary glands are specialized organs responsible for nour-
ishing newborn via producing and secretion of milk. Different from most
other organs that are patterned during embryonic development, the
mammary gland undergoes dramatic morphogenetic changes after birth
(Smith, 2012; Macias and Hinck, 2012). Postnatal mammary gland
development is tightly regulated during each developmental stage
including puberty, pregnancy, lactation, and regression (Brisken and
O'Malley, 2010; Hennighausen and Robinson, 2005). Branching
morphogenesis is a defined feature during pubertal development and is
characterized by the formation of terminal end buds (TEBs) at the distal
tip of epithelial ducts. These structures drive extensive mammary ductal
tree outgrowth and bifurcation (Ball, 1998; Paine and Lewis, 2017). Once
the ductal tree reaches the limit of the fat pad by the end of puberty stage,
TEBs are totally regressed and the mammary gland is ready for the next
stage (Macias and Hinck, 2012; Ball, 1998). Throughout the female
reproductive lifetime, mammary gland adaptations are under continuous
control of systemic hormones (e.g. estrogen, progesterone) and other
factors (Brisken and O'Malley, 2010; Asselin-Labat et al., 2010; Joshi
et al., 2010). However, the role of DC-SCRIPT during mammary gland
development and tissue homeostasis has not been investigated. This
study could contribute to our understanding of the role of DC-SCRIPT in
breast cancer tumorigenesis.
We have previously shown that DC-SCRIPT is expressed by ductal
epithelial cells in the mammary gland (Ansems et al., 2010a). The ductal
tree of a mammary gland is composed of an outer layer of myoepithelium
and an inner layer of luminal epithelium. The basal epithelium layer
consists mainly of mature contractile myoepithelial cells, but also con-
tains mammary stem cells (MaSCs) (Prater et al., 2014). These
multi-potent cells have the capacity to generate both basal and luminal
layers (Lloyd-Lewis et al., 2017; Visvader and Stingl, 2014). Recently
studies have reported a striking heterogeneity within MaSCs and precise
details of cell fate decision need further studies (Trejo et al., 2017; Fu
et al., 2017; Wang et al., 2015). Within the luminal compartment, pop-
ulations of progenitors and functionally differentiated cells can be
distinguished by established cell surface markers (Giraddi et al., 2015;
Shehata et al., 2012). Differentiated or mature luminal cell subsets,
including hormone-sensing ER positive cells, are defined as
Sca1þCD49b cells, while the precursor populations have a
Sca1CD49bþ and Sca1þCD49bþ phenotype (Giraddi et al., 2015; She-
hata et al., 2012).
In this study, the expression of DC-SCRIPT in mouse mammary gland
epithelial cells was evaluated as well as its impact on mammary gland
morphogenesis. Our results show that DC-SCRIPT is expressed in both
basal and luminal epithelium. Studies using littermate wild-type mice
and DC-SCRIPT deficient mice revealed that mammary gland morpho-
genesis was dramatically impaired in the absence of DC-SCRIPT during
puberty and early adult stage. Furthermore, DC-SCRIPT deletion delayed
mammary gland organoid branching in vitro in 3D organoid cultures.
Collectively, these findings demonstrate for the first time that DC-SCRIPT
plays an important role in controlling mammary gland development.
2. Materials and methods
2.1. Antibodies and reagents
The following primary antibodies were used: CD31-PE (1:80 dilution,
Antibodychain, Cat. #1112040), CD31-PE/Cy7 (1:80 dilution, eBio-
science, Cat. #25-0311-82), TER119-PE (1:80 dilution, eBioscience, Cat.
#12-5921-81), TER119-PerCP (1:80 dilution, Antibodychain, Cat.
#1181130), CD45.2-BV510 (1:100 dilution, Antibodychain, Cat.
#1149185), CD45.2-PerCP (1:200 dilution, BD, Cat. #552950), CD24-
BV510 (1:100 dilution, Biolegend, Cat. #101831), EpCAM-FITC (1:400
dilution, eBioscience, Cat. #11-5791-82), CD49f-APC (1:400 dilution,
eBioscience, Cat. #17-0495-80), Sca1-APC/Cy7 (1:100 dilution, Bio-
legend, Cat. #108125), CD49b-PE/Cy7 (1:50 dilution, eBioscience, Cat.
#25-5971-82), Rabbit monoclonal anti-Keratin 8 antibody (1:200 dilu-
tion, Abcam, Cat. #ab53280), Rabbit Polyclonal anti-Keratin 14 antibody
(1:200 dilution, Biolegend, Cat. #905301). Mouse monoclonal anti-DC-
SCRIPT antibody (891ug/ml, 1:90 dilution) were produced in-house.
The following isotypes were used: purified Mouse IgG isotype (Bio-
legend, Cat. #400102), purified Rabbit IgG isotype (Cell Signaling
Technology, Cat. #3900S). The following secondary antibodies were
used: Alexa fluor 488 conjugated donkey anti-Rabbit IgG (1:400 dilution,
Molecular Probes, Cat. #A21206), Cy3 conjugated donkey anti-Mouse
IgG (1:100 dilution, Jackson ImmunoResearch, Cat. #715-166-151).
The following reagents were purchased and used: Growth Factor
Reduced Matrigel (Corning, Cat. #354230), DNAse I (Roche, Cat.
#11284932001), TrypLE (Gibco, Cat. #12605–010), DMEM/F12 (Gibco,
Cat. #11330057), FGF2 (Sigma, Cat. #F0291-25UG), Collagenase A
(Sigma, Cat. #C5138–1F), Insulin-transferrin-selenium-X, (Gibco, Cat.
#51500), Antibiotic-Antimycotic (100X) (Gibco, Cat. #15240062),
TRIzol reagent (Invitrogen, Cat. #15596026), SYBR Green Master
(Roche, Cat. #4673492001), Carmine (Sigma, Cat. #C1022), Aluminum
potassium sulfate (Sigma, Cat. #A7167), Histosafe (Adamas Instru-
menten B.V.), DNase I (amplification grade, Invitrogen, Cat.
#18068015), Hexamers (Invitrogen, Cat. #N8080127), Moloney Murine
Leukemia Virus (M-MLV) Reverse Transcriptase (Invitrogen, Cat.
#28025013).
2.2. Mice
All mice used were 3–18 weeks old female mice on a C57BL/6
background. DC-SCRIPT knockout mice (DC-SCRIPT/) and control
littermate wild-type mice (DC-SCRIPTþ/þ) were bred and housed at the
Animal Research Facility of the Radboud University Medical Center. All
animal experiments were documented and approved by the Animal
Experimental Committee of the Radboud University Medical Center and
were performed in accordance with regulatory standards of the Animal
Experimental Committee.
2.3. Generation of DC-SCRIPT knockout mice
DC-SCRIPT (Zfp366) knockout mice were generated at Washington
University by deletion of a 2306bp fragment containing the ATG trans-
lation initiation codon and all of exon 2 (Fig. S1A). Briefly, the targeting
construct was linearized and electroporated into a B6-albino (B6(Cg)-
Tyrc2J/J) embryonic stem cell line. One clone carrying the correctly
modified Zfp366 locus was identified by Southern blot analysis and PCR,
expanded and injected into C57BL/6 blastocysts to produce chimeric
mice as previously described (Riegert and Gilfillan, 1999). Chimeras
were initially bred to B6-albino mice to easily assess germline trans-
mission; the presence of the targeted Zfp366 allele was confirmed by PCR
analysis. Targeted mice were further intercrossed or bred with transgenic
mice expressing the Cre recombinase under control of the CMV promoter
(B6.C-Tg(CMV-cre)1Cgn) to generate DC-SCRIPT total knockout mice
(Schwenk et al., 1995). For continued maintenance of the line,
DC-SCRIPT knockout mice were backcrossed onto a C57BL/6J
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background and offspring were identified by PCR genotyping (Fig. S1B).
All protocols were carried out in accordance with and approved by the
Institutional Animal Care and Use Committee at Washington University
in St. Louis, MO.
2.4. Mendelian ratio and growth curve analysis
For Mendelian ratio calculation, heterozygous female DC-SCRIPT
mice aged 7–9 weeks were mated with heterozygous male DC-SCRIPT
mice. 312 live pups in total were obtained from 25 different parent
pairs during one whole year breeding. The genotype of all pups was
determined and the percentage of pups with different genotype was
calculated. For growth-curve analysis, in total 456 mice with different
ages were obtained and body weight was recorded from DC-SCRIPT/
mice and their littermate controls.
2.5. Mammary whole mount carmine staining and morphological analysis
The right inguinal mammary gland (#4) was excised and whole-
mounted on a glass slide. After fixing in Carnoy's solution (75%
ethanol, 25% glacial acetic acid) overnight at 4 C, the mammary gland
was rehydrated in ethanol with decreasing concentrations (70%, 50%
and 0%) and stained with carmine red overnight at 4 C. Then the
mammary gland was dehydrated progressively in increasing concentra-
tions of ethanol (70%, 95%, and 100%) and cleared in Histosafe for lipid
removal. Stained mammary glands were imaged in a tile scan pattern of
Leica DMI6000 epi-fluorescence microscope fitted with a 10x objective.
Images were analyzed and quantified with Image J software. Briefly,
mammary epithelium surface area was quantified as the region occupied
by mammary epithelial ducts from the primary stalk to all terminal ends
of the branching network. For ductal distance measurement, the ductal
length of mammary gland in 7 weeks and 18 weeks old mice was
determined by measuring the distance between the center of the lymph
node and the end of the longest duct. In 3 weeks old mouse, the ductal
length of mammary gland was not measured as the ducts did not yet
reach the lymph node. Total branch point number was quantified as the
total number of primary, secondary and tertiary branches from the pri-
mary stalk of each ductal network. Furthermore, the total number of
TEBs was counted in 7 and 8 weeks old mice.
2.6. Immunofluorescence microscopy
Mammary glands sections were prepared for immunofluorescence
staining after being dissected from mice. Briefly, mammary glands were
fixed in 4% paraformaldehyde overnight at 4 C and thereafter
embedded in paraffin and sectioned (4 μm). For immunofluorescence
staining, sections were deparaffinized and rehydrated. After boiling in
retrieval solution for 30min for antigen retrieval, sections were treated
with blocking buffer for 30min at room temperature and were subse-
quently incubated in primary antibodies overnight at 4 C, followed by
incubation in secondary antibodies for 45min at 37 C. Nuclei were
stained and visualized using DAPI (406-diamidino-2-phenylindole) with
incubation at room temperature for 15min. Images were captured with a
Leica DM 6000 microscope using IP-lab imaging software (Scanalytics
Inc., Fairfax, VA, USA).
2.7. Mammary gland organoids isolation
Mammary glands (#3, #4 and #5) were freshly dissected from female
mice for isolating mammary gland fragments after removing the lymph
node as described previously (Nguyen-Ngoc et al., 2015; Plaks et al.,
2015). Briefly, mammary glands were minced and digested in 2 μg/ml
collagenase A solution (10ml DMEM/F12, 5 μg/ml insulin, 5% fetal
bovine serum, 1% Antibiotic-Antimycotic) for 35min at 37 C with
shaking at 150 rpm. After digestion, samples were washed with
DMEM/F12 and enriched by centrifugation. Then samples were
subjected to DNase I (40 U/ml) treatment and followed by differential
centrifugation to enrich mammary glands fragments.
2.8. Single cell preparation, flow cytometry analysis and cell sorting
Single-cell suspensions of mammary epithelium were generated from
mammary gland fragments by digesting them in TrypLE for 15min at
37 C. Single cells were treated with blocking buffer for 10min at 4 C
and were stained with antibodies as listed above with incubation at 4 C
for 30min. Subsequent flow cytometry analysis was conducted on a FACS
Verse (BD Biosciences) and Fluorescence-activated cell sorting (FACS)
was performed on a FACS ARIA III (BD Biosciences). Fixable Viability
Dyes (FVD) eFluor™ 450 was added to distinguish dead and live cells.
Data were analyzed using FlowJo V10 software (Tree Star).
2.9. 3D mammary gland organoid culture and branching assay
3D mammary gland organoid cultures and branching quantifications
were described previously (Nguyen-Ngoc et al., 2015; Plaks et al., 2015).
Briefly, mammary gland organoids (50–100) from 18 weeks old female
mouse were embedded in 50 μl Growth Factor Reduced Phenol-Red Free
Matrigel in 24 wells plates and grown in organoid medium (DMEM/F12,
1% Antibiotic-Antimycotic, 1% Insulin-transferrin-selenium-X and
50 ng/ml FGF2). Medium was refreshed every two days. Branching was
quantified on day 4, day 5 and day 6. Briefly, organoids were divided into
4 grades based on branching status: Grade 0, no branches; Grade 1, 1–3
branches; Grade 2, 4–6 branches; Grade 3, more than 6 branches. The
percentage of each grade organoid was calculated by dividing the total
number of corresponding grade organoids to the total amount of orga-
noids in each well. Organoids from three wells per mouse were quantified
per experiment, in total data were collected from 4 mice of each
genotype.
2.10. RNA preparation and quantitative RT-PCR
Sortedmammary epithelium or organoids samples were directly lysed
in TRIzol Reagent for total RNA extraction. RNA quantity and purity were
determined on a NanoDrop 2000/2000c spectrophotometer (Thermo
Scientific). After treatment with DNase I, RNA was reverse transcribed
into cDNA by using random hexamers and M-MLV reverse transcriptase
according to the manufacturer's instructions. Quantitative RT-PCR was
performed in a CFX96 sequence detection system (Bio-Rad) with SYBR
Green as the fluorophore and gene-specific oligonucleotide primers to
determine the mRNA levels for the genes of interest. Reaction mixtures
and program conditions were used as recommended by the manufacturer
(Bio-Rad). Quantitative PCR data were analyzed with the CFX Manager
software (Bio-Rad) as described before (Hontelez et al., 2013), and
mRNA levels were calculated according to the cycle threshold method
(Livak and Schmittgen, 2001). The primers (from forward to reverse) for
mouse genes were listed below:
DC-SCRIPT (Zfp366): ACCAGTGTCATCTCTGCTAC, CATTCTGTTG
AATTCCTTCC;
Hmbs: CCTACCATACTACCTCCTGGCTTTAC, TTTGGGTGAAAGA
CAACAGCAT;
Keratin 14 (Krt14): CCTCTGGCTCTCAGTCATCC, TGAGCAGCATGTA
GCAGCTT;
Keratin 8 (Krt8): ATCGAGATCACCACCTACCG, CTGAAGCCAGGGC
TAGTGAG;
CD11c: CTGGATAGCCTTTCTTCTGCTG, GCACACTGTGTCCGAA
CTCA.
2.11. Statistical analysis
All statistical analyses were conducted on Graphpad Prism 5 software
using Student's t-test; P values of less than 0.05 were considered
significant.
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3. Results
3.1. DC-SCRIPT/ mice breed and grow abnormally
To understand the physiological functions of DC-SCRIPT, we suc-
cessfully generated DC-SCRIPT/ mice. Strikingly, DC-SCRIPT/ mice
could only be obtained by breeding female DC-SCRIPTþ/- mice, not using
DC-SCRIPT/ female mice. Breeding of female DC-SCRIPTþ/- mice with
male DC-SCRIPTþ/- mice (25 couples in total) for a one-year period
yielded an offspring of 312 mice. Genotyping of the offspring revealed
that the ratio of DC-SCRIPTþ/- (N¼ 196) to DC-SCRIPTþ/þ (N¼ 97) pups
was approximately 2 to1 in accordance with the theoretical Mendelian
Ratio. In contrast, only 6% of the total offspring was DC-SCRIPT/
(N¼ 19) representing only 8% (N¼ 13) of total female pups (N¼ 162)
and 4% (N¼ 6) of total male pups (N¼ 150), respectively (Fig. 1A). An
alternative breeding strategy using DC-SCRIPT/ male mice and DC-
SCRIPTþ/- female mice yielded only one alive DC-SCRIPT/ pup (data
not shown). Analysis of the gender ratio amongst the entire 312 pups
further showed that the ratio between females and males was around 1 to
1 in both DC-SCRIPTþ/þ (56 females and 41 males) and DC-SCRIPTþ/-
(93 females and 103 males) pups, while the ratio value exceeded 2 in DC-
SCRIPT/ offspring with 68% females (N¼ 13) and only 32% males
(N¼ 6), respectively (Fig. 1B). Finally, we noted that DC-SCRIPT/
offspring was smaller in size than age-matched wild-type littermates (DC-
SCRIPTþ/þ). Analysis of the body weight of mice revealed that DC-
SCRIPT/ mice were significantly lighter than their DC-SCRIPTþ/þ lit-
termates, independent of age or gender (Fig. 1C and D).
3.2. DC-SCRIPT deficient mice show a delay in mammary morphogenesis
in vivo
To better understand the role of DC-SCRIPT in mammary gland
development, we focused on its role in mammary gland morphogenesis
in DC-SCRIPT/ mice and their littermate controls. Hereto, the archi-
tecture of mammary glands was investigated using whole-mount mam-
mary glands (Fig. 2A). Compared to control 3 weeks old DC-SCRIPTþ/þ
mice, rudimentary mammary epithelial ducts occupied smaller area and
exhibited fewer amount of total branch points in DC-SCRIPT/ mice
(Fig. 2A, C). Of note: ductal length was not measured in these 3 weeks old
mice since the rudimentary mammary epithelial ducts did not reach the
lymph node and TEBs were not yet formed. Direct ductal tree visualiza-
tion of 7 weeks old mice at puberty uncovered that mammary gland
ductal elongation and bifurcation were significantly impaired in DC-
SCRIPT/ mice compared to wild-type littermates, which was
confirmed by statistical analysis of ductal invasion area and distance
(Fig. 2A, C). Consistently, mammary ducts from 7 weeks old DC-
SCRIPT/ mice had fewer TEBs and total number of branch points
(Fig. 2B and C). Examination of ductal morphogenesis in virgin adult
mice revealed the presence of tertiary branches and ductal elongation in
both 18 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/ mice, whereas
ductal branching morphogenesis was still repressed in DC-SCRIPT/
mice (Fig. 2A, C). Interestingly, TEBs regressed completely in adult wild-
type mice, leaving behind blunt-ended ductal termini, while in adult
littermate DC-SCRIPT/ mice TEBs were still detectable (Fig. 2B),
indicative of delayed TEB regression.
3.3. DC-SCRIPT is expressed in basal and luminal mammary epithelium
Mammary gland ducts are known as bilayered structures composed of
an inner luminal cell layer and an outside basal myoepithelial cell layer.
Previously, DC-SCRIPT was shown to be expressed by cells of epithelial
origin (Ansems et al., 2010a). To characterize the DC-SCRIPT expressing
cells in mouse mammary epithelium more precisely, different mammary
epithelial subpopulations were sorted based on CD49f and EpCAM
Fig. 1. DC-SCRIPT/ mice breed and grow abnormally.
A) Percentage of DC-SCRIPTþ/þ, DC-SCRIPTþ/- and DC-SCRIPT/ offspring of a heterozygous breeding strategy (312 pups in total). B) The percentage of male and
female pups in DC-SCRIPTþ/þ, DC-SCRIPTþ/- and SCRIPT/- mice (312 mice in total). C) Representative image showing of a DC-SCRIPTþ/þ and DC-SCRIPT/ female
mouse. D) Growth curve of male and female mice from DC-SCRIPTþ/þ and DC-SCRIPT/ mice respectively (456 mice in total, Student's t-test, p< 0.05).
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expression by FACS (Fig. S2). Subsequent quantitative PCR analysis was
performed on FACS-sorted basal and luminal epithelial cells of the
mammary gland at puberty (7 weeks old) and virgin adult mice (18
weeks old). Interestingly, DC-SCRIPT mRNA expression was detected in
both basal and luminal epithelium of the mammary gland in both
developmental stages (Fig. 3A). RNA expression analysis of the basal and
luminal specific epithelium marker keratin 14 and keratin 8, respec-
tively, confirmed the purity of sorted mammary epithelial fractions.
Importantly, expression of the DC marker CD11c was not detected in
either of the sorted mammary epithelial samples, demonstrating that the
epithelium was not contaminated with DCs that are known to express
DC-SCRIPT mRNA (Fig. 3A). In concordance with the quantitative PCR
data, double immunofluorescence staining for epithelial markers and
DC-SCRIPT confirmed the presence of DC-SCRIPT protein in both keratin
14þ basal epithelium and keratin 8þ luminal epithelium located within
the epithelial bilayer, which was detected in DC-SCRIPTþ/þmice but not
in DC-SCRIPT/ littermate mice (Fig. 3B). Detectable nuclei staining of
DC-SCRIPT protein was exhibited in a small number of mammary
Fig. 2. Deletion of DC-SCRIPT delays mammary morphogenesis
A) Representative whole-mount staining of mammary glands from 3 weeks, 7 weeks and 18 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/ mice respectively, scale bar
3 mm. B) Representative whole-mount staining showing terminal morphology of mammary gland ducts from 7 to 18 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/mice
respectively, scale bar 1mm. C) Quantification of ductal area, ductal length, total branch points and TEB number of mammary gland from DC-SCRIPTþ/þ and DC-
SCRIPT/ mice, Error bars represent mean  S.E.M. (Data are collected from 3 mice of each group, Student's t-test, *p < 0.05, **p < 0.01, n.s, not significant).
Fig. 3. DC-SCRIPT is expressed in mammary epithelium.
A) mRNA expression level of DC-SCRIPT, Krt14, Krt8 and CD11c in basal and luminal epithelium is determined by quantitative RT-PCR on FACS sorted single cells from
mammary gland of 7 and 18 weeks old C57BL/6 mice. Error bars represent mean S.E.M. (Data are collected from 6 mice of each group). B) Protein expression of DC-
SCRIPT, KRT14 and KRT8 is detected by immunofluorescence staining in mammary gland paraffin section from 7 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/ mice
respectively, scale bar 15 μm.
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epithelial cells in DC-SCRIPTþ/þ mice (Fig. 3B).
3.4. DC-SCRIPT deficiency changes mammary tissue stoichiometry in
adult mice
Mammary glandmorphogenesis depends on homeostasis between the
different mammary epithelial subsets (Visvader and Stingl, 2014; Oakes
et al., 2014a). To determine the effect of DC-SCRIPT deficiency on
epithelial homeostasis within the mammary gland, epithelial sub-
populations were enumerated in mature virgin adult glands (18 weeks)
by flow cytometry using the markers EpCAM and CD49f (Fig. S2, Fig. 4A
and Fig. S3). Our data show large variation in the luminal (EpCAM-
highCD49flow) to basal cells (EpCAMlowCD49fhigh) ratio (L/B) between
different mice of similar age within the same group. We did, however,
observe a mean L/B ratio of 0.67 in DC-SCRIPTþ/þmice, while littermate
DC-SCRIPT/ mice show a mean L/B ratio of 0.98 (Fig. 4A). Although
this difference did not reach significance, these data may suggest that loss
of DC-SCRIPT tends to change epithelium homeostasis. Of note: charac-
terizing the basal and luminal population based on the epithelial cell
markers EpCAM and CD49f was highly comparable to using the markers
CD24 and CD49f (Fig. S3). Subsequently, precursor and mature cell
subsets within the heterogeneous luminal subpopulation were examined
using the previously reported cell markers Sca1 and CD49b (Giraddi
et al., 2015). The ratio of luminal precursor cells
(EpCAMhighCD49flowSca1þ/CD49bþ) to mature luminal
(EpCAMhighCD49flowSca1þCD49b) cells was dramatically decreased in
DC-SCRIPT/ mice compared to DC-SCRIPTþ/þ mice (Fig. 4B). These
data thus confirm that DC-SCRIPT has a significant impact on mammary
epithelium homeostasis, in particular on the luminal subpopulation
within the mammary gland.
3.5. DC-SCRIPT deletion delays mammary gland organoid branching in
vitro
To study the impact of DC-SCRIPT on the kinetics of mammary
branching morphogenesis in more detail, we made use of a 3D mammary
gland organoid model. Ex vivo 3D organoid cultures showed that mam-
mary organoids developed and were able to branch using cells derived
from both DC-SCRIPTþ/þ and DC-SCRIPT/ mice (Fig. 5A). Interest-
ingly, the phenotype of organoids was more cystic-like with limited
branching in DC-SCRIPT/ as compared to the more compact branched
phenotype in DC-SCRIPTþ/þ on day 4 (Fig. 5A). However, these differ-
ences gradually reduced as both groups developed towards a more fully
branched compact phenotype on day 6 (Fig. S4). To further quantify the
status of mammary gland branching morphogenesis, organoids were
categorized into different grades according to their branching status
Fig. 4. Deficiency of DC-SCRIPT changes mammary tissue stoichiometry in adult mice
A) Representative FACS analysis of luminal (EpCAMhighCD49flow) and basal (EpCAMlowCD49fhigh) subpopulations from the mammary gland of 18 weeks old DC-
SCRIPTþ/þ and DC-SCRIPT/ mice. Bar graph shows the quantification of the ratio of luminal subpopulations to basal subpopulations. Error bars represent
mean S.E.M. (Data are collected from at least 5 mice per group, Student's t-test). B) Representative FACS analysis of mature luminal subset (Sca1þCD49b) and
luminal precursor subset (Sca1þCD49bþ and Sca1CD49bþ) in mammary luminal subpopulations from 18 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/ mice. Bar
graph shows the quantification of the ratio of luminal precursor subset to mature luminal subset. Error bars represent mean  S.E.M. (Data are collected from 4 mice
per group, Student's t-test, *p < 0.05).
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(Fig. 5B). Strikingly, compared to organoids from DC-SCRIPTþ/þ, orga-
noids derived from DC-SCRIPT/ mice showed a remarkably higher
percentage of non-branched and partially branched organoids (Grade 0,
1 and 2) and a lower percentage of fully branched organoids (Grade 3) on
days 4 and 5 (Fig. 5C). These data confirmed that branching morpho-
genesis in mammary gland organoids at early time points was signifi-
cantly delayed in the absence of DC-SCRIPT. Subsequent quantification
of branching status at day 6 showed that both DC-SCRIPTþ/þ and DC-
SCRIPT/ organoids continued to branch, thereby dramatically
increasing the percentage of fully branched organoids (Fig. S4). Alto-
gether, our ex vivo findings demonstrate that DC-SCRIPT deficiency
delayed mammary organoid branching morphogenesis thereby repro-
ducing the findings in DC-SCRIPT deficient mice.
4. Discussion
The early loss of DC-SCRIPT expression during malignant trans-
formation of ductal mammary epithelial cells led us to investigate the
role of DC-SCRIPT in normal mammary gland development. Our data
show that DC-SCRIPT is expressed in both basal and luminal epithelium
and can affect epithelial cell homeostasis within the mammary gland.
Moreover, our data in DC-SCRIPT deficient mice show that DC-SCRIPT
plays an important role in controlling mammary gland morphogenesis,
affecting mammary gland elongation and bifurcation. Using a 3D mam-
mary gland organoid culture system, we demonstrate that DC-SCRIPT
deletion delays but does not prevent branching of mammary gland
organoids in vitro.
Our previous studies have shown that DC-SCRIPT is a multifunctional
transcription factor playing a significant role in breast cancer cell pro-
liferation as well as cell cycle progression (Ansems et al., 2010a, 2015).
Indeed, the presence of the transcription factor DC-SCRIPT is a favorable
prognostic factor for ER positive breast cancer patients (Ansems et al.,
2010a; Sieuwerts et al., 2010). The murine ortholog of DC-SCRIPT is
highly conserved and contains >80% homology to the human
DC-SCRIPT protein (Triantis et al., 2006b). To elucidate the physiological
function of DC-SCRIPT, analysis of DC-SCRIPT deficient mice could be
rewarding. In our current study we have for the first time used
DC-SCRIPT/mice to evaluate the function of DC-SCRIPT. These studies
were hampered by the observation that deletion of DC-SCRIPT not only
impaired the growth of the mice, but simultaneously affected the
reproductive capacity of female mice. The impact of DC-SCRIPT on the
reproductive capacity of mice is in line with DC-SCRIPT being a
multi-functional factor involved in various regulatory processes,
including the regulation of the estrogen and progesterone hormone NRs
(Ansems et al., 2010b). Unfortunately, our preliminary data on selected
hormones (progesterone, testosterone) tested in the circulation on a
limited number of available mice revealed huge mouse-mouse variations
in hormone levels and did not reveal significant differences in hormone
levels between adult mice of different genotypes. In addition, currently
unknown additional functions of DC-SCRIPT beyond our previous studies
may be involved as well, and are the topic for our further investigations.
Furthermore, in the very limited number of DC-SCRIPT/mice analyzed
so far, we did not discern an increase in tumorigenesis although this may
require aging of the mice.
Fig. 5. DC-SCRIPT deletion delays mammary gland organoids branching in vitro
A) Representative image of in vitro cultured mammary gland organoids on day 4 derived from 18 weeks old DC-SCRIPTþ/þ and DC-SCRIPT/mice, scale bar 300 μm.
B) Representative images for grading of branching in organoid. Grade 0, no branches; Grade 1, 1–3 branches; Grade 2, 4–6 branches; Grade 3, more than 6 branches.
C) Quantification of mammary gland organoid branching in vitro from DC-SCRIPTþ/þ and DC-SCRIPT/mice on day 4 and 5, respectively. Error bars represent mean
 S.E.M. (Data are collected from 4 mice per group, Student's t-test, *p < 0.05, **p < 0.01, ***p < 0.001, n.s, not significant).
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Given the relationship between breast tumorigenesis and mammary
gland development (Visvader, 2009; Oakes et al., 2014b), we first
investigated the role of DC-SCRIPT in mammary gland development.
During postnatal mammary gland development remarkable structural
alterations occur that are controlled by numerous regulators (Hennigh-
ausen and Robinson, 2005; Sternlicht, 2006; Strange et al., 2007). His-
tological examination of whole-mounted mammary glands uncovered
that DC-SCRIPT/ mice exhibit impaired ductal morphogenesis, impli-
cating DC-SCRIPT as a novel regulator in mammary gland development.
Most strikingly, in the early developmental stage, underdevelopment of
the embryonically established rudimentary mammary tree was already
detected in DC-SCRIPT/ mice. These data are in line with the major
effects on the branching morphogenesis during puberty in DC-SCRIPT/
mice. The difference in mammary morphogenesis between
DC-SCRIPT/ and littermate wild-type mice is gradually disappearing
with increasing age. These data imply that DC-SCRIPT deficiency delays
but does not block mammary gland development. TEBs are unique
structures present in puberty and crucial for driving mammary duct
elongation and bifurcation (Morris and Stein, 2017). DC-SCRIPT defi-
ciency leads to fewer TEBs and total number of branch points in 7 weeks
old mice. The importance of DC-SCRIPT in TEBs is further supported by
the finding that also in adult DC-SCRIPT/ mice the regression of TEBs
is postponed. Due to the impaired reproductive capability of female
DC-SCRIPT/ mice, its role in mammary gland morphogenesis during
pregnancy could not be evaluated in the current study. Conditional or cell
type-specific DC-SCRIPT/ mouse models may be required to study the
effect of DC-SCRIPT in mammary gland morphogenesis during different
developmental stages.
A 3D culture model of organoids is a powerful tool to study mammary
gland morphogenesis in vitro as it mimics the mammary gland structur-
ally and functionally (Kretzschmar and Clevers, 2016; Jamieson et al.,
2017). In addition, 3D mammary gland organoid culture enables evalu-
ation of the impact of specific factors in mammary gland morphogenesis
in a defined culture environment (Nguyen-Ngoc et al., 2015; Furuta and
Bissell, 2016). Mammary gland organoids cultured from DC-SCRIPT/
mice and littermate wild-type mice both successfully grew and branched
in the 3D organoid culture system, demonstrating that mammary gland
morphogenesis in vitro can occur independent of DC-SCRIPT. However,
during early stage of organoid branching morphogenesis, loss of
DC-SCRIPT dramatically delayed branching of organoids. These data
imply that DC-SCRIPT expression is important for organoid branching at
the early stages and are consistent with our in vivo data showing that
DC-SCRIPT deficiency significantly delays but does not terminally
diminish mammary gland development. Besides affecting organoids
branching, we cannot yet exclude that DC-SCRIPT deletion has some
additional, more subtle effects on organoid morphogenesis. In this
context we have noted a slight difference in cystic-like and compact
branched phenotypes of organoids derived from DC-SCRIPTþ/þ and
DC-SCRIPT/ mice in vitro that requires further studies.
The epithelium of mammary ductal tree is organized as a bilayer
composed of inner luminal epithelium and outer basal epithelium (Smith,
2012). We therefore investigated the expression of DC-SCRIPT mRNA in
these two major epithelial populations. Interestingly, DC-SCRIPT mRNA
is detected in both the basal and the luminal epithelial subpopulation. In
line with relatively low DC-SCRIPT mRNA expression level detected in
both epithelial cell populations, we noted that only few cells express
detectable DC-SCRIPT protein levels. This heterogeneity of protein
expression is known to exist within the luminal and basal subpopulation
(Oakes et al., 2014b; Pal et al., 2017).
Previously, in wild type mice different L/B ratios have been reported
(Shehata et al., 2012; Smalley et al., 2012) and they even seem to
dynamically change during growth (Dong et al., 2016). Interestingly, we
also found a large variation in L/B ratio between mice and our data
pointed toward an increased L/B ratio in the absence of DC-SCRIPT. This
observation is consistent with delayed mammary gland development in
DC-SCRIPT/mice, as a decrease in the ratio between luminal and basal
mammary epithelium subpopulations has previously been related to
aging of mice (Dong et al., 2016). Together with the finding that
DC-SCRIPT deletion decreases the ratio of precursor to mature cells
within luminal population, our data suggest that DC-SCRIPT expression is
necessary to maintain a proper hierarchical relationship between the
distinct subpopulations within the mammary epithelium. Characterizing
the impact of DC-SCRIPT expression on mature and progenitor basal
subpopulations will also be interesting, but is much more complex as
markers for these subpopulations still need to be defined. In future
follow-up studies it will be important to define which specific cell subsets
express DC-SCRIPT within the basal and luminal epithelium. The 3D in
vitro organoid model system, in combination with the DC-SCRIPT defi-
cient mice should allow to elucidate this and the molecular mechanism
by which DC-SCRIPT regulates mammary gland (organoids)
morphogenesis.
5. Conclusion
In conclusion, the data presented in this study indicate that DC-
SCRIPT represents a novel regulator of mammary gland branching and
development. Studying the role of DC-SCRIPT in mammary gland
morphogenesis will be important for understanding its role in breast
cancer tumorigenesis.
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